#65LAB has awarded its inaugural grant to Associate Professor Lena Ho from Duke-NUS Medical School to further her team's research in developing first-in-class therapeutics for chronic inflammation. Learn more about this milestone here: https://lnkd.in/ghyRNnTF
Polaris Partners
Venture Capital and Private Equity Principals
Boston, MA 13,165 followers
Investors in transformative healthcare and biotechnology companies. Trusted advisors to entrepreneurs and operators.
About us
Exceptional entrepreneurs. Remarkable bonds. Extraordinary companies. Since 1996, Polaris has been guided by the fundamental beliefs that people come first and true partnerships make all the difference. Rooted in mutual respect and a shared passion for innovation, our relationships with outstanding visionaries principally in technology and healthcare have helped to change the world for the better.
- Website
-
http://www.polarispartners.com/
External link for Polaris Partners
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 11-50 employees
- Headquarters
- Boston, MA
- Type
- Privately Held
- Founded
- 1996
Locations
-
Primary
One Marina Park Drive
Boston, MA 02210, US
-
One Letterman Drive Building C
Suite C3600
The Presidio of San Francisco San Francisco, CA 94129, US
-
27 Union Sq West
Suite 204
New York, NY 10003, US
Employees at Polaris Partners
Updates
-
Congratulations to Morphic Therapeutic on this exciting milestone. The company has signed a definitive agreement to be acquired by Eli Lilly. Bravo!
-
Bravo to SOVATO on this milestone in remote, robotic-assisted surgery.
We are excited to share the successful completion of multiple remote robotic-assisted procedures using the Sovato Platform. The demonstration included seven surgeons across multiple specialties performing surgery over a 500-mile distance between Lincoln, NE, and Chicago, IL. The shared confidence felt by the surgeons in performing a remote robotic surgery was at the core of the results. As Francesco Bianco, MD, FACS. put it, "I could not tell the difference between doing surgery in my operating room or in an operating room that was 500 miles away." Thank you to Virtual Incision for your ongoing partnership and the use of the MIRA Surgical System for making these preclinical tests a success. We are just getting started! #Telesurgery #RemoteSurgery #RoboticSurgery #Innovation
Sovato Announces Multiple Successful Remote Robotic-Assisted Procedures Over a 500-Mile Distance with the Use of the Sovato Platform
businesswire.com
-
Faraday Pharmaceuticals, Inc. completes the enrollment of 2,300 patients in its pivotal Phase 3 trial.
Faraday Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 Iocyte AMI-3 Trial of FDY-5301
globenewswire.com
-
Wellthy announces an important partnership with Guardian Life to support working caregivers. The company's platform combines human expertise and precision technology and is leading the way in helping families balance work and care responsibilities.
Exciting news — Guardian Life and Wellthy have announced a groundbreaking new partnership to support working caregivers! The partnership will offer Guardian members access to comprehensive and customized support, designed to support caregivers’ well-being at all phases of life — regardless of whether they are caring for themselves or others. With the partnership, Guardian becomes the first insurance carrier to include caregiving support services in employer-provided disability insurance. “Family caregivers are unsung heroes, waking up every day and taking on responsibilities related to an ever-growing spectrum of care,” said Wellthy CEO Lindsay Jurist-Rosner. “The partnership between Guardian and Wellthy is a significant step forward in providing comprehensive support to caregivers in our workforce, helping ensure they have the resources and guidance they need to thrive both at work and at home." Read more about this partnership in the announcement here: https://lnkd.in/eNVdKT5Q #wellbeing #innovation #partnerships
Guardian and Wellthy launch new partnership to support working caregivers and inspire well-being | Guardian
guardianlife.com
-
Cohere Health, a clinical intelligence company that provides prior authorization solutions, announces a strategic partnership with Medical Mutual and Rhyme.
Cohere Health, Medical Mutual, and Rhyme, today announced a strategic partnership that completely automates the end-to-end prior authorization process when clinically appropriate: https://lnkd.in/ezfTDHX6 Cohere Health's intelligent prior authorization platform will streamline Medical Mutual's process by digitizing and automating all authorization requests, regardless of source.
-
-
Kudos to QurAlis on its exclusive license agreement with Lilly for QRL-204, an ASO designed to restore UNC13A function in ALS, FTD, and other neurodegenerative disease.
QurAlis is excited to announce that we have entered into an exclusive license agreement with Eli Lilly and Company under which QurAlis is granting Lilly global rights to develop and commercialize QRL-204, a potentially best-in-class splice-switching #ASO that restores #UNC13A function in #ALS, #FTD, and other #neurodegenerativediseases. #precisionmedicine Read more in our press release https://bit.ly/3R6QMT5
QurAlis Grants Lilly Exclusive Global License for QRL-204, a Potentially First-in-Class Precision Therapy That Restores UNC13A Function in ALS and FTD
https://www.quralis.com
-
Exciting news for Faro Health Inc. and its Study Designer Tool, which is part of the company's digital clinical development platform.
We are proud to announce the results of a new study conducted in collaboration with Merck that showed our Study Designer Tool, when applied to #pharma clinical trial protocol development, made it easy to visualize, quantify and recommend trial improvements. Our Study Designer Tool compared a lean design approach, which starts from a “ground zero” schedule of assessments before adding changes, to the traditional copy-and-paste method, which uses a past, complete schedule of assessments. The Tool showed that for certain #clinicaltrials, when using lean design, there would be less burden to study participants, trial sites and staff, a reduction in overall costs, and a shorter trial. Said Our CEO Scott Chetham: “This study demonstrates that when immediate, measurable feedback is generated by a patient-centric, digital tool, it can reduce the cost, time and burden of conducting clinical studies. This empowers clinical teams to focus on what matters and make smart, strategic decisions to improve their trial design and the overall experience for patients.” Link to today’s press release: https://shorturl.at/IWi3e
-
-
ByHeart, the three-time Clean Label Project Certified brand, announces its continued retail expansion - its next-generation infant formula is now available at Publix.
ByHeart's Infant Formula Now Available at Publix, Underscoring Demand for the Science-Backed Clean Label Brand Across the US Market
prnewswire.com